A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Di Meo, F., Iyer, A., Akama, K., Yu, C., Cheng, R., Cesarano, A., Marino, S., Aljoufi, A., Soni, R., Roda, J. M., Sissons, J., Vu, L. P., Guzman, M. L., Huang, K., Roodman, D. G., & Perna, F. (2022). A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma. Blood, 140(Supplement 1), 671–672. https://doi.org/10.1182/blood-2022-167584
Authors:
Francesco Di Meo
Anjushree Iyer
Keith Akama
Christina Y. Yu
Rujin Cheng
Annamaria Cesarano
Silvia Marino
Arafat Aljoufi
Rajesh K. Soni
Julie M. Roda
James Sissons
Ly Vu
Mónica L. Guzmán
Kun Huang
David Roodman
Fabiana Perna
Affiliated Authors:
Rajesh K. Soni
Mónica L. Guzmán
Publication Type:
Article
Unique ID:
10.1182/blood-2022-167584
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: